Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Prospect Capital | PSEC | Nov 22, 2024 | 4.83 | +3.87 |
Prospect Capital A Pref | PSEC-A | Nov 22, 2024 | 19.15 | +0.53 |
Prosperity Bancshares | PB | Nov 22, 2024 | 84.30 | +2.38 |
Protagenic Therapeutics | PTIX | Nov 22, 2024 | 0.65 | +6.91 |
Protagonist Therapeutics | PTGX | Nov 22, 2024 | 46.46 | +11.55 |
Protalix Bio Therapeutics | PLX | Nov 22, 2024 | 1.69 | +1.81 |
Protara Therapeutics | TARA | Nov 22, 2024 | 2.39 | +4.37 |
Prothena | PRTA | Nov 22, 2024 | 14.60 | +1.11 |
Proto Labs | PRLB | Nov 22, 2024 | 41.50 | +4.43 |
Provident Bancorp | PVBC | Nov 22, 2024 | 11.39 | +2.06 |
Provident Financial | PROV | Nov 22, 2024 | 15.72 | -0.88 |
Provident Financial Services | PFS | Nov 22, 2024 | 21.40 | +2.64 |
Prudential ADR | PUK | Nov 22, 2024 | 15.93 | -0.81 |
Prudential Financial | PRU | Nov 22, 2024 | 127.89 | +1.29 |
Ps International Group | PSIG | Nov 22, 2024 | 0.56 | +4.46 |
PSQ Holdings | PSQH | Nov 22, 2024 | 2.14 | -2.28 |
Psychemedics | PMD | Nov 22, 2024 | 2.34 | -0.21 |
Psyence Biomedical | PBM | Nov 22, 2024 | 0.04 | -7.45 |
PT Telkom Indonesia (Persero) Tbk ADR | TLK | Nov 22, 2024 | 17.08 | +0.77 |
PTC | PTC | Nov 22, 2024 | 197.64 | +2.54 |
PTC Therapeutics | PTCT | Nov 22, 2024 | 43.23 | +0.79 |
PTL LTD - Ordinary Shares | PTLE | Nov 22, 2024 | 4.84 | 0.00 |
Public Service Enterprise | PEG | Nov 22, 2024 | 92.40 | +0.05 |
Public Storage | PSA-R | Nov 22, 2024 | 18.05 | +0.50 |
Public Storage | PSA | Nov 22, 2024 | 337.58 | +0.52 |
Public Storage F Pref | PSA-F | Nov 22, 2024 | 23.22 | +0.13 |
Public Storage G Pref | PSA-G | Nov 22, 2024 | 23.35 | -0.04 |
Public Storage H Pref | PSA-H | Nov 22, 2024 | 24.75 | -0.04 |
Public Storage I Pref | PSA-I | Nov 22, 2024 | 22.21 | +0.36 |
Public Storage J Pref | PSA-J | Nov 22, 2024 | 21.25 | +0.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.